About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PRognOstiC valuE of rEd Density in Ulcerative Colitis

NCT04408703·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Universitaire Ziekenhuizen KU Leuven

With

Sapporo Medical University
Imelda GI Clinical Research Center

Age

16–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Confirmed diagnosis of UC for at least 3 months
Clinical remission with SCCAI \<3 at baseline and stable remission for the last 3 months
Ability to give informed consent by the patient or legal representative in case of minority.

You may not be if

Any contraindication for sigmoidoscopy or undergoing biopsies of the rectosigmoid.
Uncontrolled coagulopathy.
Any planned change in UC related treatment (both escalation and de-escalation) after the baseline endoscopy
Planned UC related surgery
Previous subtotal or total colectomy
Short bowel, ileostomy or colostomy
Pregnancy at baseline
Age younger than 16 years

The record

StatusCompleted

PhaseNo phase

Taking part243

StartedAug 2020

UpdatedJun 27, 2024

Conditions

Ulcerative Colitis

Where2

Imelda GI clinical research center
Bonheiden, Belgium
UZ Leuven
Leuven, Belgium

Clareo Health | PRognOstiC valuE of rEd Density in Ulcerative Colitis